alexa Zhiwei Hu | Ohio State University
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Zhiwei Hu

Zhiwei Hu Editor-in-Chief
Zhiwei Hu
Associate Professor
Ohio State University College of Medicine

Dr. Zhiwei Hu is an associate professor in the Department of Surgery of The Ohio State University College of Medicine. Prior to this position, he was a Research Scientist (Research Associate Professor) in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. Dr. Hu is one of first few scientists who proposed to target both the tumor cells and tumor neovasculature. Subsequently he successfully co-invented/developeda novel Icon molecule for dual neovascular- and cancer cell-targeted immunotherapy. As co-inventor, he holds 4 US patents of Icon and its uses. The Icon has been tested for immunotherapy of cancer, aged-related macular degeneration (AMD) and endometriosis in preclinical studies. Icon immunotherapy is currently being tested in Phase I clinical trials for AMD patients. Recently his laboratory developed another targeted therapeutics, namely factor VII (fVII)-targeted photodynamic therapy (fVII-tPDT) using fVII peptides-conjugated photosensitizers for cancer (including chemoresistant cancer) and AMD. He is a member of the Yale Cancer Center, American Association for Cancer Research, and The American Association of Immunologists. He is an Adjunct Professor of Sichuan University School of Medicine and Nanchang University School of Medicine in China, and a Scientific Advisor for Iconic Therapeutics Inc. In 2011 he was elected as Vice President of the Chinese Association for Science and Technology in Connecticut (CAST-CT). Dr. Hu is a peer reviewer for numerous scientific journalsin immunology, photodynamic therapy and cancer research and serves as an editorial board member of The Journal of Immune Based Therapies, Vaccines and Antimicrobials, The Journal of Analytical &Bioanalytical Techniques, Advances in Breast Cancer Research, Open Journal of Immunology, Open Journal of Apoptosis, The Journal of Cancer Research and Treatment and Dataset Papers in Medicine. Starting February 2012, he serves as Editor-in-Chief of The Journal of Analytical &Bioanalytical Techniques.

Research Interest

Tumor Immunology, Natural Killer Cells, Antibody Immunotherapy, Adenoviral Gene Therapy, Targeted Photodynamic Therapy, Tumor Angiogenesis, Tumor Stem Cells, Molecular Biology, DNA Recombinant Techniques, Phage Display Antibody


Global Speakers in the subject

Global Experts in the subject


Photodynamic Therapy as an Emerging Treatment Modality for Cancer and Non-Cancer Diseases
Zhiwei Hu, Nancy Oleinick and Michael R Hamblin
Editorial: J Anal Bioanal Tech 2014, S1:e001
DOI: 10.4172/2155-9872.S1-e001
Dual-Targeting of Tumor Cells and Tumor Neovasculature by Tissue Factor- Targeted Photodynamic Therapy
Zhiwei Hu
Editorial: J Anal Bioanal Techniques 2012, 3:e105
DOI: 10.4172/2155-9872.1000e105
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version